GeoVax Labs, Inc. (GOVX) › Operating IncomeGeoVax Labs, Inc. (GOVX) — Operating IncomeAnnual figures by period end, from SEC filings.2009-12-31: -$3.32M2010-12-31: -$2.77M2011-12-31: -$2.35M2012-12-31: -$2.14M2013-12-31: -$2.29M2014-12-31: -$2.74M2015-12-31: -$2.69M2016-12-31: -$3.27M2017-12-31: -$2.17M2018-12-31: -$2.56M2019-12-31: -$2.37M2020-12-31: -$2.82M2021-12-31: -$18.75M2022-12-31: -$14.03M2023-12-31: -$26.74M2024-12-31: -$25.14M2025-12-31: -$21.64M-$21.64M2009-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$21.64M—2026-04-15From 2025-01-012024-12-31-$25.14M—2026-04-15From 2024-01-012023-12-31-$26.74M—2025-03-27From 2023-01-012022-12-31-$14.03M—2024-02-29From 2022-01-012021-12-31-$18.75M—2023-03-23From 2021-01-012020-12-31-$2.82M—2022-03-09From 2020-01-012019-12-31-$2.37M—2021-03-23From 2019-01-012018-12-31-$2.56M—2020-03-24From 2018-01-012017-12-31-$2.17M—2019-03-26From 2017-01-012016-12-31-$3.27M—2019-03-26From 2016-01-012015-12-31-$2.69M—2018-03-23From 2015-01-012014-12-31-$2.74M—2017-03-24From 2014-01-012013-12-31-$2.29M—2016-03-16From 2013-01-012012-12-31-$2.14M—2015-03-20From 2012-01-012011-12-31-$2.35M—2014-03-14From 2011-01-012010-12-31-$2.77M—2013-03-18From 2010-01-012009-12-31-$3.32M—2012-03-30From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)